Add to balance / Manage account | User: | Log out |
Prospect News home > News index > List of issuers O > Headlines for OpGen, Inc. > News item |
OpGen reports plans for $11.5 million at-the-market sales agreement
Agent Cowen and Co. to conduct offering, will be paid a 3% commission
By Devika Patel
Knoxville, Tenn., Sept. 13 – OpGen, Inc. arranged an $11.5 million at-the-market sales agreement with Cowen and Co., LLC, according to a prospectus supplement filed Tuesday with the Securities and Exchange Commission.
Cowen will be paid a 3% commission.
Proceeds will be used for research, development and manufacturing of product candidates and for other general corporate purposes.
OpGen is a Gaithersburg, Md.-based company that uses molecular testing and bioinformatics to help combat multi-drug-resistant bacterial infections.
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.